Carbapenems, our one-time silver bullet for multidrug resistant bacterial infections, are now threatened by widespread dissemination of carbapenem-resistant Enterobacteriaceae (CRE). Successful expansion of Enterobacteriaceae clonal groups and frequent horizontal gene transfer of carbapenemase expressing plasmids are causing increasing carbapenem resistance. Recent advances in genetic and phenotypic detection facilitate global surveillance of CRE diversity and prevalence. In particular, whole genome sequencing enabled efficient tracking, annotation, and study of genetic elements colocalized with carbapenemase genes on chromosomes and on plasmids. Improved characterization helps detail the co-occurrence of other antibiotic resistance genes in CRE isolates and helps identify pan-drug resistance mechanisms. The novel ␤-lactamase inhibitor, avibactam, combined with ceftazidime or aztreonam, is a promising CRE treatment compared to current colistin or tigecycline regimens. To halt increasing CRE-associated morbidity and mortality, we must continue quality, cooperative monitoring and urgently investigate novel treatments.
Introduction
Carbapenems are the favored last resort drugs for treatment of multidrug resistant (MDR) bacterial infections. Accordingly, spreading carbapenem resistance is a global health crisis. Carbapenems are ␤-lactam antibiotics that bind to penicillin binding proteins and inhibit cell wall synthesis. Meropenem, doripenem, ertapenem, and imipenem are the four most clinically used carbapenems (Nicolau, 2008) .
Enterobacteriaceae are a family of diverse Gammaproteobacteria which include common (Klebsiella pneumoniae, Escherichia coli, Salmonella enterica) and rare (Proteus mirabilis, Raoultella planticola, Citrobacter freundii) human pathogens with increasing antibiotic resistance. The Clinical Laboratory Standards Institute defines Enterobacteriaceae as carbapenem-resistant if they have minimum inhibitory concentrations (MICs) of ≥2 g/ml against ertapenem and ≥4 g/ml against doripenem, meropenem, or imipenem (Patel, 2015) . In a 2013 US Centers for Disease Control and Prevention (CDC) report, carbapenem-resistant Enterobacteriaceae (CRE) were listed as one of the three most urgent antimicrobial resistant threats. CREs received this highest threat level due to rapidly increasing global spread, propensity for multidrug resistance, and high mortality during blood stream infections (BSI) (Bell et al., 2013) .
Carbapenem resistance can arise from ␤-lactam ring hydrolysis by dedicated carbapenemase enzymes or from changes in membrane permeability via mutations in efflux pumps or porins coupled with extended spectrum ␤-lactamase (ESBL) expression. Carbapenemases come from ambler Class A or D serine ␤-lactamases and ambler class B metallo-␤-lactamases (MBLs). K. pneumoniae carbapenemase (KPC-Class A), New Delhi metallo-␤-lactamase (NDM-Class B), Verona integron-encoded metallo-␤-lactamase (VIM-Class B), Imipenemase metallo-␤-lactamase (IMP-Class B), and Oxacillinase-48 (OXA-48-Class D) variants are the most common carbapenemases in carbapenemase producing Enterobacteriaceae (CPE) and thus our focus in this review, but several emerging Class A enzymes are also described (Meletis, 2016) . Carbapenemase production is concerning given high occurrence of carbapenemase genes on MDR plasmids transferred both within Enterobacteriaceae and to other bacterial families (Harmer and Hall, 2015) .
This review highlights recent work documenting CRE prevalence, detecting CRE, and describing MDR patterns to optimize therapeutic strategy.
Class A ␤-lactamases
The first Class A carbapenemase was reported in 1990 in a Serratia marcescens isolate from the United Kingdom (Yang et al., 1990 ).
Many Class A carbapenemases were identified after the discovery of S. marcescens enzyme one (bla SME-1 ), including Guiana extendedspectrum two (bla GES-2 ), K. pneumoniae carbapenemase (bla KPC ), imipenemase/non-metallocarbapenemase-A (bla IMI/NMC ), Serratia fonticola carbapenemase one (bla SFC-1 ), and bla SHV-38 (Henriques et al., 2004; Poirel et al., 2003 Poirel et al., , 2001 Rasmussen et al., 1996; Yigit et al., 2001 ). Many bla GES variants are only ESBLs but frequent point mutations confer increased hydrolytic properties against carbapenems for specific variants (Dang et al., 2016a,b) . Phylogenetic alignment of Class A carbapenemase genes determined that bla SME , bla GES , bla KPC , and bla IMI/NMC constitute a separate group from bla SFC-1 and bla SHV-38 (Walther- Rasmussen and Hoiby, 2007) . Similar to other Class A ␤-lactamases, Class A carbapenemases are inhibited by clavulanic acid and tazobactam (Bush and Jacoby, 2010) . While KPC is the most common Class A carbapenemase in Enterobacteriaceae, sporadic cases of previously discovered enzymes such as SME and NMC and new gene discoveries necessitate molecular characterization to identify potentially pandemic carbapenemases before they spread (Nordmann et al., 2011; Poirel et al., 2007) .
KPC
As reported in 2001, bla KPC was discovered in carbapenem resistant K. pneumoniae from the United States and it is largely responsible for conferring carbapenem resistance in CRE infections in the western hemisphere (Gaiarsa et al., 2015; Yigit et al., 2001) . Unlike the previously characterized Class A carbapenemases (bla NMC and bla SME ), bla KPC is plasmid borne which facilitated its rapid appearance in non-K. pneumoniae Enterobacteriaceae (Hossain et al., 2004; Miriagou et al., 2003; Yigitet al., 2003) . KPC's efficient carbapenem hydrolysis confers high levels of carbapenem resistance in the absence of complementary membrane permeability changes or ESBL expression, setting it apart from other serine ␤-lactamases (Poirel et al., 2007) . In the UCLA Hospital system from January 2011 to January 2013, a few (0.73%) Enterobacteriaceae isolates were CRE, but an overwhelming proportion of those isolates (78.3%) had KPC associated carbapenem resistance (Pollett et al., 2014) .
Regardless of location, 97% of whole-genome sequenced, KPCproducing K. pneumoniae belong to the clonal complex 258, demonstrating the global dissemination of member sequence types (Gaiarsa et al., 2015) . Analysis of ST258 isolates identified two clades due to divergence in capsular polysaccharide synthesis (cps) genes . Association of cps-1 with bla KPC-2 and cps-2 with bla KPC-3 suggests that variation in KPC is due to point mutations following cps recombination, rather than horizontal gene transfer via Tn4401 (Bowers et al., 2015) . However, a two year-long study of admitted patients in five Colombian hospitals found a majority (62%, 120/193) of carbapenem-resistant K. pneu- Dortet et al. (2015a) moniae isolates were non-258 group members, but overall, KPC was the predominant carbapenemase (Ocampo et al., 2016) . ST258 was identified for the first time in a collection of CPE Isolates from Taiwan. Although KPC was the most common (85.8%, 157/183) carbapenemase found, it was largely associated with K. pneumoniae ST11 (Tseng et al., 2015) . Since ST258 is a hybrid strain of ∼80% ST11, there is potential for rapid proliferation of the clone throughout the region (Adler et al., 2015a,b) . WGS identified a novel KPC encoding mosaic plasmid, pKp28, associated with an outbreak from an endoscope at a single hospital in the United States from January 2011 to July 2013. bla KPC-2 was found on a Tn4401 transposon with 99.99% nucleotide identity to pKpQIL, while a downstream region had 99.99% identity to pHg, another plasmid associated with ST258 (Marsh et al., 2015) . bla KPC-2 was also discovered in the canonical hypervirulent K. pneumoniae ST23 (Cejas et al., 2014) . Focused genomic analyses demonstrated that CG258 isolates cluster separately from ST23, and broader results confirm that multidrug resistant isolates have little overlap with hyper-virulent ones. However, this does not preclude the possibility of plasmid exchange leading to hypervirulent and multidrug resistant K. pneumoniae expressing KPC (Bialek-Davenet et al., 2014; Struve et al., 2015) . bla KPC-2 was also identified in K. pneumoniae ST1797, a new hypervirulent strain associated with surgical wound infection in China in 2013 . Successful transfer of bla KPC containing plasmids throughout established nosocomial Enterobacteriaceae strains led to outbreaks in the United States in 2002 , and in Nepal in 2012 (Bratu et al. 2005 Chung The et al., 2015) . A comparative study of hospitals in the United States and Pakistan from February 2012 to March 2013 showed that carriage of both bla KPC and bla NDM in the same isolate is rare, but similarity in genetic background between both locations make the possibility of horizontal gene transfer likely .
Active surveillance methods should be undertaken to quickly identify KPC producers and reduce infection prevalence.
Sequence-divergent Class A carbapenemases
A novel Class A carbapenemase with 63% sequence identity to an environmental ␤-lactamase and encoding broad activity against the penicillins, cephalosporins, carbapenems, and monobactams was discovered in three carbapenem-resistant K. pneumoniae ST1781 isolates from Brazil in 2008 (Nicoletti et al., 2015) . The Brazilian Klebsiella Carbapenemase-1 (bla BKC-1 ) gene was found on a non-conjugative IncQ plasmid with aph3A-VI, a novel variant of the aminoglycoside resistance gene aph3 (Nicoletti et al., 2015) . In 2015 another novel Class A carbapenemase was identified in France from a carbapenem-resistant Enterobacter cloacae that produced a tazobactam-inhibitable carbapenemase negative for bla KPC , bla GES , bla SFC-1 , bla IMI , and bla NMC-A . The identified French imipenemase-1 (FRI-1) has significant activity against carbapenems and aztreonam, but not broad-spectrum cephalosporins; the low GC content (39%) of bla FRI-1 compared to the E. cloacae genome (55%) suggests acquisition via horizontal gene transfer (Dortet et al., 2015a,b) . Surveillance of CPE carriage at a hospital in Italy identified an Enterobacter ludwigii in August 2014 with a chromosomally integrated bla NMC-A complexed by a novel Xer-dependent integrative mobile element. Examination of publically available whole genome sequencing (WGS) data found that the element was associated with bla IMI and bla NMC-A in other members of the E. cloacae clonal complex, indicating the possibility of dissemination throughout Enterobacteriaceae (Antonelli et al., 2015) (Table 1) .
Class B ␤-lactamases
MBLs can be differentiated from Class A and D ␤-lactamases by their use of zinc instead of a catalytic serine in the active site mediated hydrolysis of ␤-lactams . Accordingly, MBLs are inhibited by metal chelators such as Ethylenediaminetetraacetic acid (EDTA) and dipicolinic acid (DPA) but not clavulanic acid or other clinically used ␤-lactamase inhibitors . They often have hydrolysis profiles against all ␤-lactams except monobactams and can confer high level of resistance when combined with changes in membrane permeability and ESBL production .
NDM
NDM is endemic to parts of Asia and is responsible for sporadic outbreaks around the globe (Zmarlicka et al., 2015) . As of August 2016 when we accessed the NCBI database, 16 variants of NDM were identified on a variety of plasmid types, corresponding to the high diversity of Enterobacteriaceae species shown to express it (NCBI, 2016; Zmarlicka et al., 2015) . A comprehensive study from 2012 to 2014 of 38,266 Enterobacteriaceae isolates collected from 40 countries spanning every inhabited continent found that global incidence of MBL presence is low (0.5%, 163/38,266), but dissemination is high (85%, 34/40 countries). bla NDM-1 was the most common gene (36.8%, 60/163) in Enterobacteriaceae (Kazmierczak et al., 2015) . The Study for Monitoring Antimicrobial Resistance Trends identified bla NDM-1 (96.3%, 130/135) as the most common variant in NDM associated infections from 2008 to 2012 across geographically diverse countries.
Population migration will undoubtedly contribute to future global spread of CRE as evidenced by the prevalence of bla NDM (59.3%, 19/32) among K. pneumoniae and E. coli isolates from Syrian patients displaced by civil strife in Europe (Lerner et al., 2016) . Copresence of ESBLs and NDM in the same isolate was high (78.5%, 106/135), but dual carbapenemase prevalence was fortunately low (1/135 with bla VIM-1 + blaNDM, 2/135 with bla OXA-181 + bla NDM ) (Biedenbach et al., 2015a,b) . A nosocomial outbreak declared in March 2014 of 19 K. pneumoniae ST10 in the neonatal intensive care unit of a Chinese hospital found that all isolates harbored bla NDM-1 on conjugative IncFI plasmids and that co-production of bla IMP-4 was common (36.8%, 7/19) but fortunately so was tigecycline, amikacin, and ciprofloxacin susceptibility (Zheng et al., 2016) . K. pneumoniae was overwhelmingly responsible for NDM production in CRE colonized patients (370/374 patients) from Poland, a non-endemic area, during a 2012-2014 outbreak (Baraniak et al., 2016a,b) . ST11 was the dominant sequence type and bla NDM-1 was the most common variant, while a mix of IncR, IncFII, and undetermined plasmids were responsible for spread (Baraniak et al., 2016a,b) . Tn3000, a novel transposon, was responsible for proliferation of bla NDM-1 among IncX3 and IncFIIk plasmids extracted from E. coli and Enterobacter hormaechei, respectively, in 2013 (Campos et al., 2015) . Whole plasmid sequencing revealed high levels of intrapatient diversity for bla NDM-1 plasmid types and host species for Enterobacteriaceae and Acinetobacter baumannii isolates obtained in Pakistan during 2010 (Wailan et al., 2015) .
Recently, bla NDM-13 , a chromosomally integrated NDM variant discovered in E. coli ST101 from Nepal in 2013, was found with a spectrum of action similar to bla NDM-1 but with increased cefotaxime affinity due to D95N and M154L mutations (Shrestha et al., 2015) . Carbapenemase production in Salmonella enterica is rare but documented for KPC and NDM (Miriagou et al., 2003; Savard et al., 2011) . bla NDM-1 was found on a conjugative IncA/C plasmid with bla CMY (Class C plasmid-mediated AmpC beta-lactamase) in an extensively drug resistant S. enterica serovar Senftenberg isolate obtained from a pediatric outpatient in India in 2012. The plasmid had multiple mobile gene elements, complicating precise determination of the genetic events that led to bla NDM-1 acquisition (Sarkar et al., 2015) . A study published in August 2014 identified two bla NDM-1 positive S. enterica serovar Agona isolates obtained from pediatric gastroenteritis infections in Pakistan (Irfan et al., 2015) . These examples demonstrate need for carbapenemase gene surveillance in S. enterica serovars, especially for MBL endemic regions.
IMP
IMP, the first identified acquired MBL, was found in a S. marcescens isolate from Japan in 1991 (Ito et al., 1995) . They are most common in China, Japan, and Australia (Nordmann et al., 2011) . Contrasting global trends, bla IMP-4 was the most common carbapenemase (82.7%, 48/58) found in July 2009 to March 2014 from hospitals in Australia. 10 Enterobacteriaceae species produced bla IMP-4 , but E. cloacae was the most frequent (60.4%, 29/48) and possessed bla IMP-4 on conjugatable HI2 (22/29 or L/M (7/29)) plasmids demonstrating a plausible mechanism for bla IMP-4 proliferation throughout the region . A pediatric patient in China in June 2014 had seven closely related bla IMP-4 producing Raoultella ornithinolytica isolated from an infected surgical wound, including the first observation of an R. ornithinolytica in China producing bla IMP-4 and bla KPC-2 (Zheng et al., 2015) . Analysis of mobile genetic elements surrounding MBLs in Enterobacteriaceae collected in Spain from February to July 2009 found that all 14 bla VIM-1 genes were associated with class 1 integrons but a mixture of genetic backgrounds (2/14 bla VIM-1 , IncU and 12/14 unidentified plasmid type) (Zamorano et al., 2015) .
VIM
VIM is largely found in Italy and Greece . VIM-1 has the closest amino acid sequence identity (32.4%) to NDM-1 . A multinational European survey of MBLproducing Enterobacteriaceae isolates collected between 2008 and 2011 found universal expression of bla VIM-1 type members (98.9%, 93/94) in nine different Enterobacteriaceae species but disproportionately high representation of K. pneumoniae ST147, ST36, and ST383 (60.6%, 57/94) from Greece (Papagiannitsis et al., 2015a,b,c) . VIM-39 is a novel bla VIM-1 type member identified in the previous study; it was found to hydrolyze meropenem, doripenem, and imipenem more efficiently than VIM-1 and conferred greater resistance to those carbapenems than bla VIM-1 in E. coli DH5␣ (Papagiannitsis et al., 2015a,b,c) . A pediatric patient from the United States was colonized by a MBL producing K. pneumoniae and later infected by a clone of the isolate in May 2014. The isolate transferred an IncA/C replicon 188-kb plasmid containing bla VIM-4 and bla CMY-4 to a recipient E. coli strain (Tamma et al., 2016) . Additionally, eight VIM-producing CRE isolates were found on six patients in the same tertiary care hospital in the United States during August 2015. Fortunately, VIM colonization was not linked with infection, but the diversity of Enterobacteriaceae species (one Raoultella spp., four E. cloacae, one E. coli, and two K. pneumoniae) and patient location (6 neonatal intensive care unit, 2 adult intensive care unit) combined with the unidentified VIM-producing source warrant further investigation of bla VIM containing plasmids (Yaffee et al., 2016) .
Class D ␤-lactamases
Class D ␤-lactamases were named oxacillinases (OXA) because they cleave oxacillin in addition to penicillin, distinguishing them from Class A ␤-lactamases. Although first characterized as extended spectrum ␤-lactamases, OXA-23 was found to confer resistance against imipenem in an A. baumannii isolate from the United Kingdom in 1985 (Donald et al., 2000) . Additional carbapenem-hydrolyzing class D ␤-lactamases (CHDLs) have also been discovered. Since 2001 OXA-23-like, OXA-40-like, OXA-51-like, OXA-58-like, and OXA-48-like family members have been found in the Enterobacteriaceae (Evans and Amyes, 2014) . CHDLs are increasing in global frequency more than the Class A and B carbapenemases (Bakthavatchalam et al., 2016) . bla OXA-48 was identified in a K. pneumoniae isolate from Turkey in 2001 and remains the most common CHDL detected (Poirel et al., 2004a,b) . A chromosomally encoded CHDL, bla OXA-54 , from the environmental bacteria Shewanella oneidensis had a 92% amino acid similarity with bla OXA-48 and comparable catalytic activity against imipenem (Poirel et al., 2004a,b) . Analysis of the flanking sequences between bla OXA-48 and bla OXA-54 suggest that bla OXA-48 originated in Shewanella spp. (Poirel et al., 2004a,b) . bla OXA-48-like family members cleave carbapenems weakly, which can lead to phenotypic susceptibility against carbapenems and therefore complicate treatment options (Bakthavatchalam et al., 2016) . Excepting OXA-163, OXA-48-like family members have little to no activity against Ceftazidine and Cefotaxime but phenotypic resistance to cephalosporins can occur in isolates co-expressing CHDLs and cephalosporin cleaving ␤-lactamases (Oueslati et al., 2015) .
OXA-48-like family members
A survey of CRE in Moscow from January 2013 to October 2014 found examples of bla OXA-48 spreading from K. pneumoniae to Proteus mirabilis, with both pathogens having nearly universal resistance (99% and 100% respectively) to three or more functional drug classes (Fursova et al., 2015) . The majority (71.9%, 87/121) of carbapenem-resistant, carbapenemase producing E. coli obtained from 2012 to 2014 in Spain possess bla OXA-48 but in a less diverse population compared to bla VIM-1 expressing isolates (Ortega et al., 2016) . Conjugatable bla OXA-48 (9/11) was the most prevalent carbapenemase detected in CPE from a hospital in Morocco collected in June to August 2011 (Barguigua et al., 2015) . The first documented instance of a community acquired UTI due to an bla OXA-48-like producing Enterobacteriaceae was in Greece in January 2010 when a recovered K. pneumoniae ST11 isolate was found with carbapenem resistance due to bla OXA-162 (Voulgari et al., 2015) . Multiple studies identified bla OXA-48 as the most prevalent carbapenemase in Spain, and this is associated with successful spread of K. pneumoniae, particularly ST11 (Branas et al., 2015; Oteo et al., 2015) . OXA-48 in the absence of other ESBLs is difficult to detect using traditional phenotypic methods due to low level of resistance against cephalosporins or carbapenems. Molecular characterization of bla OXA-48-like variants is recommended, as expression of bla OXA-48 in E. coli does not always yield carbapenem resistance in vitro, but it can prevent clearance of infections (Haverkate et al., 2015) . Emerging cases of bla in Taiwan from January 2012 to May 2014 suggest expanding ability to confer carbapenem resistance in the Enterobacteriaceae . bla OXA-48 was responsible for carbapenem resistance in a collection of Raoultella planticola isolates from January 2011 to December 2015 at a Turkish hospital (Demiray et al., 2016) . A plasmid borne bla OXA-48 contained on Tn1999.2 was reported in a R. ornithinolytica clinical isolate from Lebanon in 2016 (Al- Bayssari et al., 2016) .
Within bla OXA-48-like members, carbapenemase activity varies significantly despite few sequence changes. Purified OXA-163 was shown to hydrolyze carbapenems at efficiencies far lower than several other OXA-48-like members. When bla OXA-163 was expressed in E. coli TOP10, this correlated with MICs below the clinical breakpoint for Enterobacteriaceae carbapenem susceptibility (Oueslati et al., 2015) . However, MIC values for E. coli lacking OmpF and OmpC were above the susceptibility cut off for meropenem, doripenem, and ertapenem (Oueslati et al., 2015) . OXA-405 is a bla OXA-48 type carbapenemase without carbapenemase activity discovered in a S. marcescens isolate from France in January 2011 (Dortet et al., 2015a,b) . Similar to OXA-163, it conferred increased resistance to extended-spectrum cephalosporins and aztreonam compared to OXA-48. Rapid global spread of bla OXA-48-like expressing Enterobacteriaceae necessitates molecular detection for informed patient treatment options and documentation of epidemiological occurrences to prevent nosocomial outbreaks (Poirel et al., 2012a,b) .
Non-carbapenemase resistance mechanisms
Resistance-nodulation-division (RND) efflux pumps including the AcrAB-TolC system are a common resistance mechanism for Enterobacteriaceae and other Gram-negative bacteria against multiple antibiotic classes. Counterintuitively, KPC-2 production coupled with a loss-of-function AcrAB mutant in K. pneumoniae ECL-8 and E. coli BW25113 resulted in increased resistance against ertapenem and meropenem. Similarly, E. coli, Klebsiella spp., and Enterobacter spp. treated with the efflux pump inhibitor, phenylalanine-arginine ␤-naphthylamide (PABN), down-regulated ompF expression and had increased ertapenem resistance (Saw et al., 2016) . RND efflux pump inhibition holds promise as synergistic treatment against MDR Gram-negative bacteria, but these results indicate that pump inhibition cannot be broadly applied across antibiotic classes (Aparna et al., 2014) . Single nucleotide polymorphism (SNP) analysis between carbapenem-resistant, noncarbapenemase producing E. cloacae found that most SNPs are attributable to natural phylogenetic variation. However, SNPs in ampD leading to increased bla ampC expression combined with mutations lowering expression of ompC, ompF, or both, thus increasing carbapenem resistance as well (Babouee Flury et al., 2016) . As reported in 2015, K. pneumoniae clinical isolates from the United States and Israel with intermediate carbapenem susceptibility but lacking carbapenemase genes had more frequent porin nonsense mutations (ompK35, ompK36, and ompK37) and greater ESBL expression compared to K. pneumoniae with carbapenemases (Adler et al., 2015a,b) .
As reported in 2013, loss of OmpK35 and OmpK36 porins in a K. pneumoniae isolate from Taiwan resulted in a 32-, 8-, and 4-fold increase in the MIC to ertapenem, meropenem, and doripenem respectively, but only ertapenem was beyond the clinical resistance breakpoint (Tsai et al., 2013) . However, OmpK35/36 loss combined with expression of bla CTX-M-15 ESBL or the plasmid-mediated ␤-lactamase bla DHA-1 and its regulator ampR led to clinical resistance against ertapenem, meropenem, doripenem, and imipenem (Tsai et al., 2013) . This combination of ESBL production and porin loss is believed to have contributed to dissemination of carbapenemresistant K. pneumoniae within a tertiary-care hospital in South Korea from 2007 to 2008 (Shin et al., 2012) .
Stepwise-carbapenem resistance in the absence of a carbapenemase or ␤-lactamase was reported in Sweden in 2016 when an E. coli ompC and ompF double-deletion mutant was passaged in meropenem or ertapenem for ∼60 generations . Meropenem but not ertapenem passaging caused mutations in stringent response regulator enzymes, spoT, thrS, and tufA . Increased stringent response activity is believed to contribute to carbapenem resistance but at a substantial fitness cost .
Multiple antibiotic resistance protein A (marA) is an AraC-type transcriptional regulator (TR) responsible for antibiotic resistance in the Enterobacteriaceae primarily by controlling outer membrane permeability in coordination with two other AraC-type TRs, rob and soxS (Alekshun and Levy, 1999) . Overexpression of an additional AraC-type TR, ramA, in the K. pneumoniae NCTC 5055 reference strain increased growth around an imipenem Kirby-Bauer disk, suggesting a role in regulating carbapenem resistance (JimenezCastellanos et al., 2016) . As reported in 2013, an E. coli isolate from China lacked OmpF and OmpC porins and had a marA mutation which resulted in expression of the previously classified pseudogene yedS (Warner et al., 2013) . G42R MarA facilitated expression of the YedS porin which is believed to contribute to E. coli isolate survival in the absence of OmpF and OmpC (Warner et al., 2013) . These examples indicate that changing membrane permeability by altering efflux pumps and porin expression can confer carbapenem resistance alone or synergistically with ESBLs in the absence of a carbapenemase.
Detection
Initial CRE detection is often by analysis of susceptibility testing results from automated systems, broth microdilution assays, and Kirby-Bauer disk diffusion . Further characterization is done to differentiate carbapenemase producers from non-producers . The poor hydrolytic ability of some carbapenemases for carbapenems, most notably OXA-48-like enzymes and KPC variants, makes the appearance of carbapenem susceptible, carbapenemase producers also possible (Gagetti et al., 2016; Poirel et al., 2012a,b) . PCR-based and phenotypic assays are the two detection methods for identifying CRE and CPE .
Screening breakpoints for CPE detection are recommended by CLSI and EUCAST, but there is no consensus on the optimal breakpoints (CLSI, 2016; EUCAST, 2013) . A 2016 study suggested that CLSI screening breakpoints for CPE detection are missing carbapenem susceptible carbapenemase producers in carbapenemase isolates 14% (26/188) including 25% (14/63) of KPC producers and 40% (12/30) of OXA-48-like producers (Fattouh et al., 2016) .
The diversity of OXA-48-like carbapenemases makes precise molecular determination difficult . However, a PCR-based assay using high-resolution melt time analysis can differentiate seven bla OXA-48-like family members as well as bla KPC , bla NDM-1 , bla IMP , bla VIM , and bla SME . A multiplex PCR assay using peptide nucleic acid probes reported high sensitivity and specificity (both above 99.0%) in identifying bla KPC , bla OXA-48 , bla GES , bla IMP , bla VIM , and bla NDM from a mixture of Enterobacteriaceae isolates (Jeong et al., 2015) . One assay combined nested PCR, rtPCR, and microfluidics to obtain class level identification of carbapenemases (bla KPC , bla VIM , bla OXA-23 , bla OXA-48 , bla OXA-51 ) and ESBLs for rapid detection of diverse mul-tidrug resistant organisms including CRE (Walker et al., 2016) . A PCR-based assay for rectal swabs had high sensitivity (96.6%) and specificity (98.6%) at identifying bla KPC , bla NDM , bla VIM , bla OXA-48 , and bla IMP-1 on a rapid time-scale (32-48 min) (Tato et al., 2016) .
A comparison of disk diffusion assay detection of OXA-48-like carbapenemase producing Enterobacteriaceae from 2014 demonstrated that temocillin disk detection had similar sensitivity (all above 98%) to meropenem and piperacillin/tazobactam disk detection (Huang et al., 2014) . Use of temocillin disk detection dramatically increased specificity (92.0% for K. pneumoniae and 89.3% for other species with temocillin compared to 46.0% for meropenem and 60.5% for piperacillin/tazobactam) using modified detection cut-offs of 29 mm, 16 mm, and 12 mm for meropenem, piperacillin/tazobactam, and temocillin respectively (Huang et al., 2014) . Temocillin can also be used for detection of MBL and KPC using Disks or tablets if synergy is not detected (EUCAST, 2013) .
The Modified Hodge Test (MHT) is a phenotypic assay for detection of CPE by inactivation of carbapenems allowing increased growth of an indicator strain (Girlich et al., 2012) . However, the MHT has poor sensitivity for class B carbapenemases (sensitivity <50%) which is marginally improved by addition of ZnSO 4 (sensitivity 87%) (Girlich et al., 2012) . As reported in Argentina in 2016, addition of 0.2% Triton X-100 [vol/vol] to Mueller Hinton Agar plates improved sensitivity (97-100%) for detecting Class B carbapenemase expressing CPE . The proposed mechanism relies on the anionic detergent disturbing the hydrophobic interactions between the lipoprotein carbapenemases and the outer membrane Pasteran et al., 2016) .
Matrix-assisted laser desorption ionization-time of flight mass spectrometry (MALDI-TOF MS) has become an essential tool within Clinical microbiology laboratories for rapid identification of bacterial pathogens as well as their resistance mechanisms by comparing a clinical isolate's peptide mass fingerprint with known databases (Bohme et al., 2012) . Additionally, MALDI-TOF MS can be adapted to study small molecules. As reported in France in 2015, a MALDI-TOF MS analysis of imipenem hydrolysis by cell supernatants had 100% specificity and sensitivity at differentiating CPE (OXA-48 variants, KPC, NDM, VIM, IMI, IMP, and NMC-A) from CRE that lack carbapenemases (Lasserre et al., 2015) . The low cost per test (<0.10 USD) and rapid protocol (∼20 min) holds promise for widespread adoption by clinical microbiology labs (Lasserre et al., 2015) .
The easily interpretable Rapidec Carba NP Test showed high sensitivity and specificity (both 96%) at detecting CPE (in addition to A. baumannii and Pseudomonas aeruginosa) with an under 30-min incubation time . A phenotypic assay using imipenem, EDTA, and EDTA plus phenylboronic acid had high sensitivity (96.3%) and specificity (97.7%) in identifying OXA-48-like family members within genetically characterized CRE (Tsakris et al., 2015) . A novel colorimetric assay for carbapenemase detection showed high sensitivity (97.8%) and specificity (98.5%) at differentiating carbapenem-resistant, carbapenemase producers from non-producers (Kabir et al., 2016 ). An electrochemical assay using imipenem hydrolysis to drive redox changes was capable of detecting CPE in less than 35 min with high sensitivity (95%) and perfect specificity (100%) (Bogaerts et al., 2016) . The carbapenem inactivation method is an efficient phenotypic assay that has high concordance with PCR-based detection of carbapenemase production in Enterobacteriaceae as well as Acinetobacter and Pseudomonas species. The simple protocol and required materials makes it promising for widespread adoption by clinical microbiology labs (van der Zwaluw et al., 2015 ). An immunochromatographic assay had perfect sensitivity (100%) and specificity (100%) at detecting OXA-48-like CPE compared to isolates possessing OXA-48-like variants lacking carbapenemase activity or Class A and B carbapenemases (Dortet et al., 2016) . Accurate detection methods are important for developing ideal patient treatment options and surveillance of carbapenemases. In a study done between June 2010 to January 2014, an Italian hospital demonstrated that identification of carbapenemases by disk diffusion synergy and quarantine of CRE carriers significantly reduces incidence of high mortality BSIs (Viale et al., 2015) .
Plasmid replicons
Plasmids are extrachromosomal DNA elements that often contain genes which confer fitness to specific extracellular stressors (Carattoli, 2013) . Certain plasmids are conjugative and can be passed between members of the Enterobacteriaceae and with other gram negative pathogens such as A. baumannii and P. aeruginosa (Vilacoba et al., 2014) . Class A, B, and D carbapenemases contained on mobile gene elements within these plasmids is a core factor in the rapid spread of CRE (Mathers et al., 2015) .
IncL/M
IncL/M plasmids are self-transmissible replicons common among Enterobacteriaceae . Genomic characterization of IncL and IncM plasmid identified high nucleotide conservation (∼94%) but two distinct branches when clustered for sequence similarity . Of 20 IncL/M plasmids sequenced by 2015, 18 harbored ␤-lactamases from ambler Classes A-D including KPC, NDM, VIM, and OXA carbapenemases (Adamczuk et al., 2015) . These plasmid types were originally endemic to the Mediterranean region but have become globally disseminated (Adamczuk et al., 2015) . IncL/M plasmids containing bla OXA-48 were demonstrated to have a 40-fold higher transfer efficiency compared to plasmids with bla NDM-1 due to insertion of bla OXA-48 and its flanking transposon Tn1999 into the transfer inhibition protein gene (Potron et al., 2014) . Genetic analysis of the plasmid containing bla OXA-48 determined the absence of other antibiotic resistance genes but the presence of a Tn1999 composite transposon on the common IncL/M type backbone (Poirel et al., 2012a,b) . Given widespread dissemination of the IncL/M type plasmids among Enterobacteriaceae and presence of multiple mobile genetic elements, threat of additional antibiotic resistance genes associating with bla OXA-48 is constant but currently undocumented (Manageiro et al., 2015) .
IncX3
A single IncX3 plasmid with two bla KPC-3 copies, both associated with Tn4401, was recovered from an XDR K. pneumoniae ST512 isolate in Italy in 2014. The MICs for carbapenems were identical between the IncX3-K. pneumoniae ST512 and a K. pneumoniae ST512 with KPC on the canonical pkpQIL plasmid. IncX3 E. coli transformants had greater carbapenem resistance than the pkpQIL, but this could be due to differences in plasmid copy number or KPC expression in addition to the two bla KPC-3 genes (Fortini et al., 2016) . An E. coli ST 3835 isolate obtained in November 2012 from China contained bla NDM-1 and bla SHV-12 on the IncX3 plasmid backbone (Feng et al., 2015a,b) . This narrow-spectrum plasmid was found harboring bla NDM-1 in several Enterobacteriaceae isolates in China, suggesting a possible role in global dissemination of bla NDM-1 (Feng et al., 2015a,b) . A comparison of CPE collected from 2013 to 2014 in a Canada found that bla NDM-7 was harbored on an identical IncX3 plasmid across K. pneumoniae, E. coli, E. hormaechei, and S. marcescens, indicating frequent horizontal gene transfer events within Enterobacteriaceae (Chen et al., 2015a,b) . Five CRE collected at a hospital in China from January to September 2013 possessed bla NDM-1 on an IncX3 plasmid with high similarity in the immediate region surrounding bla NDM-1 , but one plasmid was twice as large (104.5-138.9 kb) as the other four (33.3-54.7 kb), indicating genetic exchanges during horizontal gene transmission between Enterobacteriaceae .
IncF
IncFII-type plasmids (7/12) were the most common background carrying NDM in a cohort of NDM positive isolates obtained in Australia from 2012 to 2014. IncX3 (4/12) and IncHI1B (1/12) were also identified, but every NDM variant was within Tn125 (Wailan et al., 2016a,b) . bla NDM-5 on an IncFII plasmid was found on two K. pneumoniae ST147 isolates in a suspected nosocomial transmission event at a hospital in South Korea in 2014 (Shin et al., 2016) . A K. pneumoniae isolate obtained from China in October 2010 expressed bla KPC-2 on a IncFIIK conjugative plasmid in association with a different transposon, Tn1772, indicating carriage plasticity by mobile gene elements . As reported in 2015, a patient from Spain with no recent travel history had a urine culture positive for E. coli ST448 with bla NDM-5 on a conjugatable IncFII-type plasmid (Pitart et al., 2015) . The first MBL expressing Enterobacteriaceae isolate obtained from Poland in August 2011, an E. coli ST410, was found to carry bla NDM-1 on a IncFII plasmid (Fiett et al., 2014 ). An IncFIIy type plasmid containing NDM and three ESBLs (bla TEM , bla CTX-M-1 , and bla OXA-1 ) together was isolated from the first instance of a carbapenem-resistant Leclercia adecarboxylata from China in August 2012 (Sun et al., 2015) . In Europe, clonal group 258 is the primary source of KPC producing K. pneumoniae, with the eponymous ST258 being the most common (69.1%, 76/110) followed by ST512 (19.1%, 21/110) (Baraniak et al., 2016a,b) . Both predominantly possess IncFIIB and IncFIBK, contrasting with non-CG258 K. pneumoniae and other CPE species which mostly possess IncN plasmids (Baraniak et al., 2015) .
IncA/C
Chromosomally integrated bla NDM-1 expressing P. aeruginosa and bla NDM-1 on IncA/C plasmid in E. coli were obtained from the same patient (Mataseje et al., 2016) . As reported in 2016, IncA/C2 and IncFIIy plasmids carrying NDM in Enterobacteriaceae from Australia and New Zealand all had segments with high sequence similarity to Acinetobacter plasmids, further documenting frequent genetic exchange with non-Enterobacteriaceae members (Wailan et al., 2016a,b) . Multidrug resistant IncA/C plasmids containing integrons In4863 (bla ) were identified in two carbapenemresistant K. pneumoniae ST383 isolates with suspected origin from Greece in 2009 to 2011 (Papagiannitsis et al., 2016) . Multidrug resistant, conjugative IncA/C plasmids were recovered from two K. pneumoniae ST11 isolates obtained from a hospital in Bulgaria in 2014. The larger (176-kb) plasmid possessed bla NDM-1 with bla CMY-4 , bla CTX-M-15 , bla TEM-1b , and qnrB while the smaller (86-kb) plasmid had bla NDM-1 with bla TEM-1 , and aac(6')-Ib (Todorova et al., 2016) . bla OXA-48 has additionally been identified on an IncA/C plasmid in Taiwan (2015) and Tunisia (2011) (Ktari et al., 2011) .
Other
A K. pneumoniae ST25 isolate obtained from a Portuguese ICU in 2009 possessed bla IMP-8 on a ColE1-like plasmid in association with a novel class 3 integron that also contained the weak carbapenemase bla GES-5 , aacA4, and bla BEL-1 , an ESBL only identified in P. aeruginosa previously. Formerly, these genes were found solely on class 1 integrons; this suggests a resistance cassette exchange between class 1 and 3 integrons, with potential IncQ plasmid involvement, may be responsible (Papagiannitsis et al., 2015a,b,c) .
bla NDM-1 was discovered on a BJ01-like plasmid in an E. aerogenes isolate from China in June 2012 (Chen et al., 2015a,b) . Since previous reports of pNDM-BJ01 have exclusively been in Acinetobacter, this identification confirms that horizontal gene transfer between Gammaproteobacteria is a continual occurrence (Chen et al., 2015a,b) .
The first instance of the narrow-spectrum plasmid, IncT, containing bla NDM-1 was from a Providencia rettgeri isolate colonizing a patient in Canada who received medical care in India in 2015 (Mataseje et al., 2016) .
Non-infectious surveillance
Prediction of carbapenemase dissemination is complicated by the discovery of new reservoirs for antibiotic resistance genes. An E. coli CMUL 64 specimen isolated from domesticated chickens in Lebanon in December 2013 contained bla OXA-48 in addition to two ESBLs (Al Bayssari et al., 2015) . Surveillance of Silver Gull (Chroicocephalus novaehollandiae) excrement from South-East Australia in October 2012 found that CPE carriage was alarmingly high (71.8%, 120/167) and almost completely due to bla IMP-4 (96.7%, 116/120), but bla IMP-26 (1.67%, 2/120) and bla IMP-38 (5.83%, 7/120; 5/7 in E. coli ST58 co-producing bla IMP-4 ) were also detected . This agrees with clinical observations reporting bla IMP-4 as the most prevalent gene from CPE clinical isolates in Australia, indicating either high transmission frequency of bla IMP-4 to human pathogens or that these CPE environmental isolates can be infectious agents . Contrasting with the seemingly high carriage of CPE in birds, CPE are absent (0.6%, 1/160) from studied companion dog fecal microbiota in Madrid, Spain from October 2014 to January 2015 excepting one K. pneumoniae ST2090 expressing bla VIM-1 on an untyped plasmid (Gonzalez-Torralba et al., 2016) . Similarly, WGS analysis of fecal microbiota collected from dairy cows in the southwestern United States from May to July 2014 failed to detect any CRE, though it did find other carbapenemresistant Gram-negative bacteria (Webb et al., 2016) .
Assessment of individual carriage potential demonstrated that recent antibiotic therapy, immunosuppression, and a Charlson Comorbidity Index >4 are all significant predictors of CRE infection (Miller and Johnson, 2016) . A US case report from February 2016 indicates that the Middle East may be another reservoir for bla NDM genes in addition to the Indian subcontinent and the Balkans (Li et al., 2016) . Identifying intra-hospital carriage of CRE is important given the high fatality rate from CRE infections in patients with solid organ transplants from endemic areas (Satlin et al., 2014) .
A study published in 2016 identified bla IMI-3 on a IncFIIY plasmid obtained from sediment at the Haihe River in China showed high genetic similarity with IncF plasmids from pathogenic Enterobacteriaceae (Dang et al., 2016a (Dang et al., , 2016b . As reported in 2016, an IncP-1␤ plasmid also obtained from sediment at the Haihe River contained a bla GES-5 variant with several amino acid substitutions that led to loss of carbapenemase activity (Dang et al., 2016a (Dang et al., , 2016b . Two E. coli isolates expressing bla IMP-8 and two E. coli isolates expressing bla VIM-1 and bla VIM-34 were obtained in February 2015 from the Ave river in northern Portugal. bla IMP-8 and bla VIM-1 were found on Inc-FIB type plasmids capable of transconjugation while bla VIM-34 was suspected to be chromosomally integrated (Kieffer et al., 2016) . As reported in 2016, water collected from Rio De Janeiro yielded many bla KPC producing Enterobacteriaceae as well as bla GES , bla OXA-48-like , and bla NDM genes amplified directly from aquatic microbial communities (de Araujo et al., 2016) . Routine environmental sampling could prove advantageous in anticipating spread of novel antibiotic resistance genes into clinical pathogens (Table 2) . 
Contribution of carbapenemases to MDR/XDR Enterobacteriaceae

Dual carbapenemases
Presence of multiple carbapenemase genes in one isolate is concerning given the possibility of different carbapenemase genes crossing onto the same plasmid. A K. pneumoniae isolate obtained in the United States in 2013 from the high risk ST258 clade expressed plasmid borne bla KPC-2 and bla VIM-4 (Castanheira et al., 2016) . An E. cloacae ST231 from China in 2012 was found to harbor bla NDM-1 on IncA/C2 mosaic plasmid and bla KPC-3 on a novel IncX6 plasmid (Du et al., 2016a (Du et al., , 2016b . These same resistance genes were found on two different IncF plasmids in an E. cloacae isolate from China in April 2014, further increasing the likelihood that a recombination event could create a dual carbapenemase plasmid . In April 2014 a K. pneumoniae ST147 strain possessing bla NDM-5 and bla OXA-181 was isolated at a hospital in South Korea from a patient native to the United Arab Emirates (Cho et al., 2015) . Four months later, a K. pneumoniae isolate with identical ST, bla OXA-181 , and bla NDM-5 genes was obtained from a patient native to South Korea with no history of travel abroad (Cho et al., 2015) . The patients did not overlap temporally or spatially, which suggests extended surface survival of K. pneumoniae (Cho et al., 2015) . This occurrence is also documented outside of K. pneumoniae; in 2016 an E. coli ST410 isolate from Egypt was found to have bla NDM-5 and bla CTX-M-15 on a transmissible ∼100 kb plasmid with 99% similarity to pHC105 and bla OXA-181 on a 48.5 kb plasmid that did not transform a recipient strain (Gamal et al., 2016a,b) . A C. freundii isolate from China in July 2013 possessed bla NDM-1 on an IncX3 type plasmid and bla KPC-2 on an untypable plasmid that is notable for a region with genes conferring resistance to macrolides (mphA-mrx-mphR operon), quinolones (aac(6 )-lb-cr), rifampin (arr-3), chloramphenicol (catB3), sulfonamides (sul1), cephalosporins (bla OXA-1 ), quaternary ammonium compounds (qacE l), chromate (chrA), and fosfomycin (fosA3) (Feng et al., 2015a,b) .
Tigecycline resistance
Tigecycline is a tetracycline derivative and one of the few remaining drugs for treating CRE infections. 56 tigecycline nonsusceptible K. pneumoniae from South Korean hospitals in 2012 showed that co-resistance with carbapenems is low (2/56) compared to ceftazidime, ceftriaxone, and aztreonam (37/56, 36/56, and 35/56 respectively) (Ahn et al., 2016) . But prior admission to a skilled nursing facility was significantly associated with tigecycline non-susceptible, carbapenem-resistant K. pneumoniae cultures in hospitalized patients (van Duin et al., 2015) . Additionally, tigecycline resistance in carbapenem-resistant K. pneumoniae bacteriuria occurred significantly following tigecycline monotherapy in a multicenter, prospective study from December 2011 to October 2013 in the United States (van Duin et al., 2014) . Clinical resistance to Tigecycline was associated with increased expression of AcrAB by marA mutations in KPC-producing K. pneumoniae isolates from China collected between January 2010 and December 2013 .
Aminoglycoside resistance
Gentamicin, amikacin, and tobramycin are aminoglycosides occasionally used to treat CRE (Morrill et al., 2015) . rmtB is a 16s rRNA methylase conferring high level aminoglycoside resistance that is commonly found on IncF, IncA/C, IncK, and IncN plasmids (Kang et al., 2008; Yu et al., 2010) . These plasmids are common in Enterobacteriaceae and indeed rmtB was found in 34% (25/74) of K. pneumoniae ST11 isolates from China in 2012 to 2014 with 97% (72/74) positive for bla KPC-2 and the remainder (2/74) positive for bla NDM-1 (Cheng et al., 2016) . Quinolone resistance genes oqxA, oqxB, and qnrB were also common in 81% (60/74), 76% (56/74), and 8% (6/74) of isolates, respectively (Cheng et al., 2016) . rmtF is a novel 16S rRNA methyltransferase which was found to confer high aminoglycoside resistance in Enterobacteriaceae isolates collected from 2009 to 2011 in India and the United Kingdom (Hidalgo et al., 2013) . 20 of the 34 rmtF expressing Enterobacteriaceae also contained NDM-1 (Hidalgo et al., 2013) . Two ST11 K. pneumoniae isolated from a tertiary care hospital in Egypt from September 2013 to December 2014 possessed bla NDM-1 and rmtF on the same untypeable 170 kb plasmid (Gamal et al., 2016a,b) .
Colistin resistance
Colistin is an old and rarely used (due to severe nephrotoxicity) polymyxin antibiotic that has emerged as a CRE treatment, making co-resistance concerning. Until the discovery of the plasmidmediated colistin resistance gene, mcr-1, resistance was attributed to chromosomal modification of the LPS biosynthesis pathway . Mcr-2, a colistin resistance gene with 76.7% nucleotide identity to mcr-1, was discovered on a conjugatable IncX4 plasmid in E. coli ST10 and ST167 from Belgium in July 2016 (Xavier et al., 2016) . The IncX4 plasmid did not contain any additional resistance genes, but mcr-2 was contained within an IS element from the IS1595 superfamily, which was associated with the carbapenemase bla in Acinetobacter radioresistens (Higgins et al., 2013) . A third (32/97) of carbapenem-resistant K. pneumoniae found in Italy from December 2010 to May 2011 displayed a colistin MIC Norgan et al. (2016) of 16 g/ml, which was associated with higher mortality compared to infection by colistin susceptible, carbapenem-resistant K. pneumoniae (Capone et al., 2013) . The first characterization of a bla IMI-1 producing, colistin resistant E. cloacae from the United States in February 2015 showed absence of mcr-1 and canonical chromosomal modifications, suggesting that Enterobacteriaceae contain other colistin resistance mechanisms (Norgan et al., 2016) . A retroactive study on colistin-resistant Enterobacteriaceae isolates obtained from January 2013 to November 2015 at a hospital in China found two K. pneumoniae harboring mcr-1 and bla NDM-5 (Du et al., 2016a,b) . Four bla KPC-2 producing K. pneumoniae ST101 from a cohort of nosocomial CRE obtained in Italy from November 2013 to August 2014 had colistin resistance (MIC 16-125 g/ml) through an unidentified mechanism (Del Franco et al., 2015) . A K. pneumoniae ST147 isolated from patient urine in the United Arab Emirates in April 2014 was phenotypically pan drug resistant by the Vitek 2 semi-automated system . Resistance to carbapenems is derived from the OXA-48-like family member, bla Oxa-181 , with contributions from an inactivating mutation in OmpK36 . The isolate was resistant to many antibiotics by acquired genes, but colistin resistance was conferred through a chromosomal copy of the bla OXA-181 transposon disrupting the mgrB allele. Tigecycline resistance was attributed to an inactivating mutation in ramR allowing for increased expression of acrAB (Table 3) .
Treatment options
Antibiotic combinations
Therapeutic potency of antibiotics can be increased (synergy), decreased (antagonism), or unaffected (additivity) when combined with other each other as determined by their fractional inhibitory concentration index (Doern, 2014) . Most widely used combinations were formulated from clinical observations of effectiveness but not heavily scrutinized for mechanistic basis of synergy (Baym et al., 2016) . Understanding how commonly used CRE infection antibiotic treatments affect each other and identifying new combinations is necessary to optimize CRE treatment.
As reported in 2015, a regimen of intravenous colistin, meropenem, and ertapenem successfully treated a bacteremic, multidrug resistant, KPC expressing K. pneumoniae infection in an elderly patient from Italy. In vitro analysis indicated synergy of colistin/ertapenem/meropenem when each antibiotic is 0.5 × MIC, with MICs of 32, 128, and 256 g/ml respectively (Oliva et al., 2015) . A retrospective study of patients who received ertapenemcontaining double-carbapenem therapy from October 2013 to November 2014 at a hospital in the United States also supported the efficacy of dual carbapenem treatment regimens, finding that ertapenem treatment followed by doripenem or meropenem had promising microbiological success (79%, 11/14) (Cprek and Gallagher, 2016) .
Resurgence of polymyxins as a CRE treatment motivated further study of other antibiotics with historically limited use, such as chloramphenicol (Abdul Rahim et al., 2015) . Colistin and chloramphenicol were synergistic in 89% (25/28) of cases against three NDM-producing MDR K. pneumoniae clinical isolates and the K. pneumoniae NDM reference strain BAA-ATCC-2146 in vitro. All chloramphenicol resistant isolates were determined by PCR to use efflux pumps, so further research is needed to see if the combination is synergistic against bacteria with carbapenemases and chloramphenicol acetyltransferases (Abdul Rahim et al., 2015) . Polymyxin B and tigecycline together and in triple combination with meropenem significantly increased rat survival during systemic infection with bla KPC-2 expressing K. pneumoniae, but the double combination had superior in vitro activity. This could be explained by antagonistic effects between polymyxin B and meropenem (Toledo et al., 2015) . While empiric antibiotic therapy has led to development of clinically useful combinations, most notably trimethoprim-sulfamethoxazole and ␤-lactam/␤-lactamase inhibitor combinations, immediate benefits from synergy may be countered by quicker evolution of resistance to these pairings (Yeh et al., 2009) . Applying systems biology to understand how antibiotic combinations interact with isolate resistomes is necessary to mechanistically understand the increased effectiveness and design collaterally sensitive formulations (Gonzales et al., 2015; Pal et al., 2015; Roemer and Boone, 2013) .
Avibactam
␤-Lactamase inhibitors have extended the spectrum and efficacy of several ␤-lactam antibiotics, and a few ␤-lactam/␤-lactamase inhibitor combinations have gained widespread clinical use (Drawz and Bonomo, 2010) . Unfortunately, our current ␤-lactamase inhibitors are ineffective against Class B ␤-lactamases; this is especially concerning given the global dissemination of NDM positive Enterobacteriaceae and regional prevalence of VIM and IMP enzymes (Watkins et al., 2013) .
Avibactam is a recent non-␤-lactam, ␤-lactamase inhibitor with broad efficacy against serine ␤-lactamases, particularly KPC (Krishnan et al., 2015) . Structural analysis showed that avibac-tam covalently binds to the S70 residue in the active site of two Class A ␤-lactamases, KPC-2 and SHV-1 (Krishnan et al., 2015) . Combining avibactam with ceftazidime, a third generation cephalosporin, shows promise as treatment for non-MBL expressing CRE (Castanheira et al., 2015; Zhanel et al., 2013) . KPC-2 engineered to be avibactam resistant had increased ceftazidime susceptibility, suggesting collateral sensitivity as an explanation for the combination's clinical efficacy . However, in a United States hospital in 2015, K. pneumoniae isolated from a patient not previously exposed to ceftazidimeavibactam treatment showed resistance to the combination (MIC 32/4 g/ml). The only identified carbapenemase was a bla KPC-3 with 100% identity to previously sequenced variants. Additionally, the ceftazidime-avibactam resistance mechanism does not appear efflux based because treatment with PABN did not decrease the MIC. The isolate was multidrug resistant, but was susceptible to aminoglycosides, colistin, and trimethoprim-sulfamethoxazole . In vitro studies suggest decreased membrane permeability via OmpK36 mutation, and the expression of an ESBL in conjunction with KPC-2, or expression of KPC-3 instead of KPC-2 correlated with increased ceftazidime-avibactam resistance (Shields et al., 2015) .
The monobactam aztreonam is resistant to inactivation by NDM, but not serine ␤-lactamases. Accordingly, high levels of NDM and serine ␤-lactamase co-occurrence reduces the clinical utility of aztreonam monotherapy (Shakil et al., 2011 ). An aztreonam-avibactam combination inhibited 99.9% (n = 23,516) of Enterobacteriaceae species at 4/4 g/ml. The combination was particularly effective against Enterobacteriaceae isolates possessing a MBL in addition to serine ␤-lactamases (Biedenbach et al., 2015a,b) . Aztreonam-avibactam activity had broader efficacy than ceftazidime-avibactam against a panel of CPE species possessing a variety of Class A, B, and D carbapenemases (Vasoo et al., 2015) . An E. cloacae ST88 isolate from a hospital in the United States with chromosomally integrated bla KPC-18 and bla VIM-1 on a 58-kb multidrug resistant IncN plasmid was reported in 2016. The E. cloacae was highly resistant to ceftazidime-avibactam (MIC->256/4) but not aztreonam-avibactam as (MIC-0.5/4) (Thomson et al., 2016) .
In 2015, avibactam-ceftazidime combined with ertapenem successfully treated a patient infected with bla NDM-1 expressing pan drug resistant K. pneumoniae at a hospital in the United States. Avibactam has not demonstrated activity against class B ␤-lactamases, but it showed in vitro synergy with ceftazidime and carbapenems (Camargo et al., 2015) . These current investigations demonstrate the utility of avibactam to extend the effectiveness of aztreonam and ceftazidime against CRE, judicious use will hopefully preserve this efficacy.
Emerging options
In addition to exploring combinations of antibiotic and resistance inhibitors, urgent work is needed to develop novel antimicrobial therapeutics to treat CRE infections and eliminate colonization. Medicinal chemistry to develop new antibiotic classes and modify current compounds to evade resistance mechanisms is key to revitalizing our arsenal against CRE (Pucci and Bush, 2013) . Immune based therapies augmenting endogenous innate and adaptive effector mechanisms are being investigated as alternatives to traditional broad spectrum antibiotics (DiGiandomenico and Sellman, 2015; Li et al., 2014) . Restoration of diverse gut microbiota by fecal microbiota transplant (FMT) is being used to restore colonization resistance against MDR enteric pathogens following antibiotic treatment (Allen et al., 2014) . Emerging synthetic tools are being used to identify genetic cytotoxicity loci that can augment or replace antibiotic treatment (Vercoe et al., 2013) .
A novel cephalosporin with a 3-position catechol moiety that acts as a siderophore to sequester ferric iron displayed low MIC values against a diverse group of CRE species and carbapenemase genes (Kohira et al., 2015) . The next generation aminoglycoside, plazomicin, had an MIC90 value of 1 g/ml against 164 Enterobacteriaceae isolates expressing Class A (bla KPC-2 , n = 34), Class B (bla VIM-1 , n = 125; bla IMP-22 , n = 1), or Class D (bla , n = 4) carbapenemases compared to MIC 90 of 256, 64, and 16 g/ml for gentamicin, tobramycin, and amikacin respectively (RodriguezAvial et al., 2015) .
Monoclonal antibodies targeting poly-(␤-1,6)-N-acetyl glucosamine, a polysaccharide implicated as an E. cloacae and K. pneumoniae virulence factor, showed significant in vivo protection against NDM-1 producing Enterobacteriaceae in a mouse peritonitis model. This target is a promising new vaccine candidate against invasive infection (Skurnik et al., 2016) . Cationic antimicrobial peptides (AMPs) are an ancient feature of multicellular immune systems that hold potential for novel bacterial infection treatments. Two piscidin family AMPs isolated from tilapia (Oreochromis niloticus) in Taiwan in 2012 exhibited in vivo bacteriostatic effects yielding superior survival outcomes compared to tigecycline and imipenem in a mouse sepsis model infected with bla NDM-1 producing K. pneumoniae (Pan et al., 2015) .
FMTs are a promising alternative to antibiotics for treatment of inflammatory bowel disorders and active Clostridium difficile infections (Surawicz et al., 2013; Wang et al., 2014) . Commensal gut flora is believed to outcompete enteric pathogens and then establish further colonization resistance (Wang et al., 2014) . As reported in 2015 from the United States, antibiotic administration to mice perturbs the intestinal microbiota enough to lose colonization resistance against vancomycin resistant E. faecium and carbapenem resistant K. pneumoniae (Caballero et al., 2015) . Pre-colonization with one pathogen does not prevent the colonization by the other, but FMT administration reduced levels of both species (Caballero et al., 2015) . This suggests the use of fecal microbiota transplants as a putative clearance method for non-infected, CRE colonized patients (Caballero et al., 2015) .
Transduction of carbapenem resistant bla NDM-1 E. coli with CRISPR/Cas9 based RNA guided nucleases for bla NDM-1 resulted in a three-log 10 reduction of bacterial CFU (Citorik et al., 2014) . The proposed mechanism relies on an increase in dsDNA breaks leading to activation of the SOS response and antibiotic independent cell death (Citorik et al., 2014) . A combinatorial TR overexpression screen in bla NDM-1 E. coli identified many gene pairs that induced lethality in the presence or absence of ceftriaxone (Cheng et al., 2014) . These results support the notion that antibiotic cytotoxicity is a result of target specific inhibition coupled to increased redox activity via a global stress response (Dwyer et al., 2014) . Further work is needed to characterize additional vulnerabilities in CRE.
Conclusion
Although individual resistance gene presence varies by geography, CRE represents a worsening global threat that ignores national borders. Within the United States, CRE are suspected to cause over 9000 cases of healthcare-associated Enterobacteriaceae infections (Yaffee et al., 2016) . Predictions indicate that infections caused by MDR bacteria will increase substantially, with MDR E. coli expected to cause 3 million deaths each year by 2050 (O'Neill, 2016) . In-depth characterization of clinical CRE isolates is necessary to identify carbapenemase burden and distribution in endemic and non-endemic areas (Lutgring and Limbago, 2016) . Additionally, surveillance of CRE in patients, the environment, and animals should be continued to identify reservoirs for carbapenemase genes (Guerra et al., 2014; Viau et al., 2016) . The diversity of plasmids containing car-bapenemase genes and propensity of these plasmids to contain multiple antibiotic resistance genes and mobile gene elements foreshadows increasing incidence of extensively drug resistant Enterobacteriaceae (Tangden and Giske, 2015) . Though avibactam with ceftazidime or aztreonam is a promising CRE treatment, developing novel antibiotic combinations and revamping the antibiotic development pipeline is required to suppress the worsening CRE threat.
